ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Syndrome
Human Influenza
Post-Acute COVID-19 Syndrome

COVID-19 trials near Pittsburgh, PA, USA:

Locations recently updated
Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Pittsburgh, Pennsylvania, United States and 111 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 123 other locations

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Smithfield, Pennsylvania, United States and 20 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Pittsburgh, Pennsylvania, United States and 214 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Pittsburgh, Pennsylvania, United States and 59 other locations

of two groups for the reduction of respiratory distress in a CoViD-19 population, using gammaCore Sapphire (nVNS) plus standard of ...

Active, not recruiting
SARS (Severe Acute Respiratory Syndrome)
Respiratory Failure
Other: Standard of care therapies
Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)
Allegheny Health Network (AHN)

Pittsburgh, Pennsylvania, United States and 1 other location

demonstrate that a booster dose of monovalent or bivalent SARS-CoV-2 vaccine given to adults previously vaccinated with an authorized/approved COVID...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1
Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03

Phase 2, Phase 3

Sanofi
Sanofi

Pittsburgh, Pennsylvania, United States and 71 other locations

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19...

Active, not recruiting
SARS-CoV-2 Infection
Drug: S-217622
Drug: Placebo

Phase 3

Shionogi
Shionogi

Pittsburgh, Pennsylvania, United States and 188 other locations

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Enrolling
SARS-CoV-2
Other: Placebo
Biological: mRNA-1273.214

Phase 2

Moderna
Moderna

Pittsburgh, Pennsylvania, United States and 51 other locations

This study will enroll individuals who have:Completed primary series of mRNA COVID-19 vaccine, andAn antibody response ≤ 2500 U/mL -...

Active, not recruiting
Liver Transplant Recipients
Kidney Transplant Recipients
Biological: Moderna COVID-19 Vaccine 2023-2024
Biological: Pfizer-BioNTech COVID-19 Vaccine 2023-2024

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 14 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems